RedHill Biopharma Ltd. (RDHL)
6.24
-0.11 (-1.73%)
At close: Jan 28, 2025, 1:19 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | 23.92M | -71.67M | -97.74M | -76.17M | -42.30M | -38.82M | -45.54M | -29.37M | -21.09M | -10.71M | -10.63M | -10.33M | -15.50M | -2.54M |
| Depreciation & Amortization | 1.99M | 8.15M | 18.15M | 8.74M | 1.21M | 90.00K | 81.00K | 44.00K | 36.00K | 27.00K | 24.00K | 24.00K | 15.00K | n/a |
| Stock-Based Compensation | 1.65M | 5.67M | 10.21M | 4.20M | 3.03M | 2.68M | 2.23M | 1.68M | 1.36M | 1.75M | 1.25M | 1.65M | 2.86M | 80.00K |
| Other Working Capital | -50.44M | 14.49M | 10.04M | 33.13M | -1.83M | 2.45M | 1.00M | 711.00K | 702.00K | -2.59M | -290.00K | -109.00K | n/a | n/a |
| Other Non-Cash Items | -47.79M | 20.65M | 5.37M | 6.03M | -347.00K | 35.00K | -123.00K | 94.00K | -69.00K | 50.00K | -70.00K | 1.47M | 8.11M | 853.00K |
| Deferred Income Tax | n/a | n/a | 123.00K | 195.00K | n/a | 136.00K | -5.08M | -1.26M | -638.00K | 8.00K | -64.00K | -73.00K | -602.00K | n/a |
| Change in Working Capital | -15.58M | 8.01M | -1.15M | 8.42M | -2.34M | 1.42M | 3.66M | 553.00K | 2.57M | -3.36M | 1.05M | 459.00K | 430.00K | -21.00K |
| Operating Cash Flow | -35.82M | -29.18M | -65.05M | -48.58M | -40.75M | -34.46M | -44.77M | -28.26M | -17.83M | -12.23M | -8.44M | -6.79M | -4.69M | -1.63M |
| Capital Expenditures | -11.00K | -198.00K | -115.00K | -53.77M | -203.00K | -58.00K | -1.18M | -120.00K | -1.63M | -1.10M | -224.00K | -108.00K | -181.00K | -1.11M |
| Acquisitions | n/a | n/a | 8.03M | n/a | 35.00K | 35.00K | 11.96M | -36.87M | 17.94M | 15.96M | n/a | 100.00K | n/a | n/a |
| Purchase of Investments | n/a | n/a | -8.50M | n/a | -4.33M | -6.98M | -34.92M | -12.25M | -29.56M | -17.00M | n/a | -1.03M | -4.59M | n/a |
| Sales Maturities Of Investments | 14.96K | 8.50M | 475.00K | 18.13M | 9.69M | 12.39M | 17.52M | 36.84M | 10.00M | 243.00K | 1.35M | 4.12M | n/a | 92.00K |
| Other Investing Acitivies | 10.00 | 8.50M | -8.03M | -35.24M | -35.00K | -35.00K | -11.96M | 36.87M | -17.94M | -15.96M | 1.14M | -100.00K | n/a | n/a |
| Investing Cash Flow | 4.00K | 8.30M | -8.14M | -35.65M | 5.16M | 5.35M | -18.58M | 24.47M | -21.19M | -17.86M | 1.13M | 2.98M | -4.77M | -1.02M |
| Debt Repayment | n/a | -1.48M | -1.68M | 76.45M | -796.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.09M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 7.48M | -10.88M | -3.39M | -15.95M | 5.00K | -139.00K | 3.44M | 263.00K | 108.00K | 5.00M | 2.18M | 302.00K | 1.18M | n/a |
| Financial Cash Flow | 21.44M | 11.45M | 73.46M | 84.37M | 35.51M | 41.76M | 25.65M | 36.02M | 54.79M | 24.37M | 2.28M | 6.55M | 13.84M | 11.09M |
| Net Cash Flow | -14.40M | -9.51M | 179.00K | 272.00K | 18.00K | 12.55M | -37.33M | 32.27M | 15.62M | -5.96M | -4.96M | 2.74M | 5.02M | 8.45M |
| Free Cash Flow | -35.83M | -29.38M | -65.16M | -102.35M | -40.95M | -34.52M | -45.95M | -28.38M | -19.46M | -13.33M | -8.66M | -6.90M | -4.87M | -2.74M |